Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-15

Clinical Trial Update: Safety and Compliance of Taking Mesalamine Once a Day in Pediatric Patients [NA]

View source ↗

Summary

A terminated pediatric trial assessed safety and compliance of once-daily mesalamine in children with Ulcerative Colitis; results are posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesalamine (Mesalamine)

Snippet

Sponsor: Annette Langseder | Conditions: Ulcerative Colitis | NA | Status: TERMINATED | Results posted: 2014-08-15